Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03PDY
|
||||
Former ID |
DNC001298
|
||||
Drug Name |
SB-332235
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Chronic obstructive pulmonary disease [ICD9: 490-492, 494-496; ICD10:J40-J44, J47] | Discontinued in Phase 1 | [547219] | ||
Company |
GlaxoSmithKline
|
||||
Structure |
Download2D MOL |
||||
Formula |
C13H10Cl3N3O4S
|
||||
Canonical SMILES |
C1=CC(=C(C(=C1)Cl)Cl)NC(=O)NC2=C(C(=C(C=C2)Cl)S(=O)(=O)<br />N)O
|
||||
InChI |
1S/C13H10Cl3N3O4S/c14-6-2-1-3-8(10(6)16)18-13(21)19-9-5-4-7(15)12(11(9)20)24(17,22)23/h1-5,20H,(H2,17,22,23)(H2,18,19,21)
|
||||
InChIKey |
WTLRWOHEKQGKDS-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 276702-15-9
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | High affinity interleukin-8 receptor B | Target Info | Antagonist | [536223] | |
NetPath Pathway | TNFalpha Signaling Pathway | ||||
Pathway Interaction Database | IL8- and CXCR2-mediated signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.